Hello everyone, this is Mario Raviglione.
I am a professor at the University of Milan, where I teach Global Health,
and I'm also an honorary professor at Queen Mary University, London.
I used to be the Director of the Global Tuberculosis Program at the World Health Organization
in Geneva, between 2003 and 2017.
This talk is part 2 of my talk on the End TB strategy.
As you'll remember from the previous talk, in part 1 I addressed the burden of tuberculosis,
international targets and the progress towards them, the challenges to be faced today,
and finally the evolution of the global strategy - the precursors - from DOTS to the End TB strategy.
In this talk I will be speaking exclusively about the End TB strategy, providing all details.
The End TB strategy (in part 1) was fully approved by the World Health Organization in 2014,
and is a strategy that accompanies the Sustainable Development Goals of the United Nations,
it's part of it, in a way.
It started in 2016, with a deadline in 2030.
In this slide you see the vision, the targets, of the End TB strategy.
We have a vision of a world free of tuberculosis, of a goal of ending the epidemic, which coincides
(not by coincidence) with the Sustainable Development Goals aims of ending the epidemic.
You see the three essential pillars of the strategy, that I'm going to describe in detail.
The first one is on integrated patient-centered TB care and prevention, it's more the approach
to the patient, it's the care part.
Pillar 2 is on the policies instead, and speaks of the bold policies and supportive systems that must be
in place, in a health system, in a country, to support the fight against tuberculosis.
Finally, pillar 3 is the one devoted to innovation and research.
At the bottom you see four layers, these are the four essential principles of the strategy.
The government has to provide stewardship, and has to be accountable.
The second one is the coalition necessary between civil society and communities.
The third one is the protection and promotion of human rights, of ethical behavior, and of equity.
Finally the last point or principle is that of the adaptation of the strategy and the targets
at the country level (locally), and the global collaboration that is necessary.
On the right, you have the targets.
These targets - which I have described in part 1 of this talk and am repeating, focusing on those
for 2030, that coincide with the Sustainable Development Goals for 2030 for tuberculosis -
are a reduction in the number of TB deaths by 90 per cent,
a reduction in the incidence of tuberculosis by 80 per cent.
What we would like to see starting in 2020, and in 2025 continuing and proceeding to 2030, is zero.
That number zero, meaning no family, no patient affected by TB should be facing catastrophic costs.
These are the main indicators, and therefore the targets are related to those indicators
that define the whole philosophy of the strategy.